Tango Therapeutics
Simon Liang is an experienced professional in the fields of research and development operations, with a strong background in oncology pharmacology and drug discovery. Currently serving as the Manager of R&D Operations at Tango Therapeutics since February 2022, Simon previously held roles at Novartis Institutes for BioMedical Research, including Senior Scientist I and Research Scientist II, focusing on in vivo experiments and pharmacokinetic/pharmacodynamics modeling. Simon's academic credentials include a Master of Liberal Arts from Harvard University and a Bachelor of Arts in Biological Sciences from the University of Chicago. Additionally, Simon has engaged in various research positions and projects at prestigious institutions, including a visiting graduate student role at MIT's Koch Institute for Integrated Cancer Research.
This person is not in any teams
Tango Therapeutics
3 followers
Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients.